DrugBiological
Eflepedocokin alfa clinical trials
Also written F-652.
- studies test it
- 5
- open now
- 1
- in phase 3
- 0
- first study started
- 2016
Keep track of what changes. Save the eflepedocokin alfa studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2016 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 2
EVIVE Biotechnology (3) · Mayo Clinic (1) · Samer Gawrieh (1)
Often tested with
Tested in the same studies.
Adrenal Cortex Hormones (1) · Prednisone (1) · Acamprosate (1)
Studies
Open first, then newest update. How each study uses eflepedocokin alfa is read from its arms, and is right about nine times in ten.
Testing it · 5
- Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) TrialRecruitingPhase 2Samer GawriehNCT07060638Written as IL-22
- Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19TerminatedPhase 2EVIVE BiotechnologyNCT04498377Written as F-652
- Study of F-652 in Subjects With Corona Virus Disease 2019 (COVID-19) PneumoniaWithdrawnPhase 2EVIVE BiotechnologyNCT05205668Written as F-652
- Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHDCompletedPhase 1/2EVIVE BiotechnologyNCT02406651Written as Recombinant Human Interleukin-22 IgG2-Fc (F-652)
- Use of F-652 in Patients With Alcoholic HepatitisCompletedPhase 1/2Mayo ClinicNCT02655510Written as F-652
Codes
What other systems call eflepedocokin alfa · ClinicalTrials.gg INT001799
- MeSH (NLM) C000721109eflepedocokin alfaOne source NLM
- UNII (FDA) ZQ9E6EX2JEEFLEPEDOCOKIN ALFAConfirmed FDA, NLM
- NCI Thesaurus C141419Eflepedocokin AlfaOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000721109 | eflepedocokin alfa | One source NLM |
| UNII (FDA) | ZQ9E6EX2JE | EFLEPEDOCOKIN ALFA | Confirmed FDA, NLM |
| NCI Thesaurus | C141419 | Eflepedocokin Alfa | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.